000 01558 a2200397 4500
005 20250515004341.0
264 0 _c20060203
008 200602s 0 0 eng d
022 _a1175-3277
024 7 _a10.2165/00129784-200505060-00003
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aHilleman, Daniel E
245 0 0 _aPharmacological management of atrial fibrillation following cardiac surgery.
_h[electronic resource]
260 _bAmerican journal of cardiovascular drugs : drugs, devices, and other interventions
_c2005
300 _a361-9 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAdrenergic beta-Antagonists
_xtherapeutic use
650 0 4 _aAmiodarone
_xtherapeutic use
650 0 4 _aAnti-Arrhythmia Agents
_xeconomics
650 0 4 _aAtrial Fibrillation
_xdrug therapy
650 0 4 _aCalcium Channel Blockers
_xtherapeutic use
650 0 4 _aCoronary Artery Bypass
_xeconomics
650 0 4 _aElectric Countershock
650 0 4 _aHumans
650 0 4 _aIncidence
650 0 4 _aLength of Stay
_xeconomics
650 0 4 _aMeta-Analysis as Topic
650 0 4 _aPostoperative Complications
650 0 4 _aPremedication
650 0 4 _aRandomized Controlled Trials as Topic
700 1 _aHunter, Claire B
700 1 _aMohiuddin, Syed M
700 1 _aMaciejewski, Stephanie
773 0 _tAmerican journal of cardiovascular drugs : drugs, devices, and other interventions
_gvol. 5
_gno. 6
_gp. 361-9
856 4 0 _uhttps://doi.org/10.2165/00129784-200505060-00003
_zAvailable from publisher's website
999 _c15886305
_d15886305